Investor Relations
Corporate Profile
Cerevel Therapeutics is tackling neuroscience diseases with a differentiated approach that combines expertise in NEUROCIRCUITRY with a focus on receptor SELECTIVITY
Financial Metrics
Minimum 15 minutes delayed. Source:
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.